• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿霉素、顺铂和异环磷酰胺联合化疗对骨转换的影响。

The effect of a doxorubicin, cisplatin and ifosfamide combination chemotherapy on bone turnover.

作者信息

Virolainen Petri, Inoue Nozomu, Nagao Masato, Frassica Frank J, Chao Edmund Y S

机构信息

Department of Orthopaedic Surgery, The Johns Hopkins University, Baltimore, Maryland 21205-2196, USA.

出版信息

Anticancer Res. 2002 Jul-Aug;22(4):1971-5.

PMID:12174872
Abstract

BACKGROUND

Use of combination adjuvant chemotherapies have improved the disease-free survival rate of tumor patients significantly. Previous experimental studies have shown that chemotherapeutic agents have negative effects on fixation of porous coated prosthesis, but the effects on normal bone turnover rate and mechanicalproperties have been reported to be minimal.

MATERIALS AND METHODS

Fourteen dogs were used to study the effect of a doxorubicin, cisplatin and ifosfamide combination in normal bone turnover. We developed a safe and clinically-relevant canine model for multidrug perioperative chemotherapy that simulates current cancer treatment. The bone specimens were analyzed using microradiography, bone histomorphometry and torsional testing. The results were compared with canines that underwent a similar surgical protocol without chemotherapy.

RESULTS

The results showed no differences in mechanical properties after 22 weeks of chemotherapy. The porosity, osteonal activity and mineral apposition rate of the cortical bone were unaffected. The results also showed no difference in porosity of perimeter in cancellous bone, but the mineral apposition rate was significantly reduced.

CONCLUSION

The difference in mineral appostion rate of cancellous bone shows that, although the effect of temporary chemotherapy on bone may have minor effects on normal turnover and that the effect may be reversible, it causes disturbance in bone mass accumulation. This may later raise the risk for fragility fractures and osteoporosis.

摘要

背景

联合辅助化疗的应用显著提高了肿瘤患者的无病生存率。以往的实验研究表明,化疗药物对多孔涂层假体的固定有负面影响,但据报道对正常骨转换率和力学性能的影响极小。

材料与方法

使用14只狗来研究阿霉素、顺铂和异环磷酰胺联合用药对正常骨转换的影响。我们开发了一种安全且与临床相关的犬类多药围手术期化疗模型,该模型模拟了当前的癌症治疗方法。使用显微放射摄影、骨组织形态计量学和扭转试验对骨标本进行分析。将结果与未接受化疗但接受类似手术方案的犬类进行比较。

结果

化疗22周后,力学性能无差异。皮质骨的孔隙率、骨单位活性和矿物质沉积率未受影响。结果还显示,松质骨周边孔隙率无差异,但矿物质沉积率显著降低。

结论

松质骨矿物质沉积率的差异表明,尽管短期化疗对骨骼的影响可能对正常骨转换影响较小且可能是可逆的,但它会导致骨量积累受到干扰。这可能会增加日后发生脆性骨折和骨质疏松症的风险。

相似文献

1
The effect of a doxorubicin, cisplatin and ifosfamide combination chemotherapy on bone turnover.阿霉素、顺铂和异环磷酰胺联合化疗对骨转换的影响。
Anticancer Res. 2002 Jul-Aug;22(4):1971-5.
2
The effect of multidrug chemotherapy on bone graft augmented prosthesis fixation.多药化疗对骨移植增强假体固定的影响。
J Orthop Res. 2005 Jul;23(4):795-801. doi: 10.1016/j.orthres.2005.01.006. Epub 2005 Mar 2.
3
Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.高剂量异环磷酰胺、高剂量甲氨蝶呤、顺铂和多柔比星用于肢体局限性骨肉瘤患者的新辅助化疗:意大利和斯堪的纳维亚肉瘤研究组的联合研究
J Clin Oncol. 2005 Dec 1;23(34):8845-52. doi: 10.1200/JCO.2004.00.5785. Epub 2005 Oct 24.
4
Effect of cisplatin chemotherapy on extracortical tissue formation in canine diaphyseal segmental replacement.
J Orthop Res. 1997 Sep;15(5):773-80. doi: 10.1002/jor.1100150521.
5
Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group.骨肉瘤:化疗中添加胞壁酰三肽可提高总生存率——来自儿童肿瘤研究组的报告
J Clin Oncol. 2008 Feb 1;26(4):633-8. doi: 10.1200/JCO.2008.14.0095.
6
Interactions of doxycycline with chemotherapeutic agents in human breast adenocarcinoma MDA-MB-231 cells.强力霉素与人乳腺癌MDA - MB - 231细胞中化疗药物的相互作用。
Anticancer Drugs. 2009 Feb;20(2):115-22. doi: 10.1097/CAD.0b013e32831c14ec.
7
Adjuvant therapy of osteosarcoma--A Phase II trial: Southwest Oncology Group study 9139.骨肉瘤的辅助治疗——一项II期试验:西南肿瘤协作组研究9139
Cancer. 2004 Feb 15;100(4):818-25. doi: 10.1002/cncr.20021.
8
Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate.骨肉瘤:一项关于在顺铂、阿霉素和大剂量甲氨蝶呤基础上加用异环磷酰胺和/或胞壁酰三肽的随机前瞻性试验。
J Clin Oncol. 2005 Mar 20;23(9):2004-11. doi: 10.1200/JCO.2005.06.031.
9
Can cure in patients with osteosarcoma be achieved exclusively with chemotherapy and abrogation of surgery?骨肉瘤患者仅通过化疗和取消手术就能治愈吗?
Cancer. 2002 Nov 15;95(10):2202-10. doi: 10.1002/cncr.10944.
10
Neoadjuvant methotrexate, vinblastine, doxorubicin and cisplatin for histologically proven lymph node positive bladder cancer.新辅助甲氨蝶呤、长春碱、阿霉素和顺铂用于组织学证实的淋巴结阳性膀胱癌。
J Urol. 2005 Jul;174(1):80-5. doi: 10.1097/01.ju.0000162018.40891.ba.

引用本文的文献

1
Complete Spontaneous Bone Regeneration following Surgical Enucleation of a Mandibular Cemento-Ossifying Fibroma.下颌骨牙骨质化纤维瘤手术摘除后完全自发骨再生
Case Rep Dent. 2022 Aug 5;2022:7902602. doi: 10.1155/2022/7902602. eCollection 2022.
2
Periosteum preservation in bone regeneration.骨再生中的骨膜保留
CMAJ. 2020 Aug 10;192(32):E920. doi: 10.1503/cmaj.200005.
3
Do long term survivors of ewing family of tumors experience low bone mineral density and increased fracture risk?尤因家族性肿瘤的长期存活者是否会出现低骨密度并增加骨折风险?
Clin Orthop Relat Res. 2014 Nov;472(11):3471-9. doi: 10.1007/s11999-014-3777-5. Epub 2014 Jul 12.
4
An osteoporotic hip fracture in a 14-year-old girl undergoing chemotherapy and operated for knee osteosarcoma.一名14岁正在接受化疗且因膝部骨肉瘤接受手术的女孩发生了骨质疏松性髋部骨折。
J Orthop Traumatol. 2009 Sep;10(3):151-4. doi: 10.1007/s10195-009-0059-1. Epub 2009 Jul 31.